Early access schemes for innovative health technologies: the views of international stakeholders.

ABSTRACT:

Objectives

Early access schemes (EASs) are approaches used by payers to balance and facilitate earlier patient access to innovative health technologies while evidence generation is ongoing. Schemes require investment from payers and are associated with significant risk since not all technologies will be routinely reimbursed. The purpose of this study was to gain the perspectives of policy experts about the key challenges for EASs and potential solutions for their optimal design and implementation.

Methods

Two virtual workshops were convened including (i) UK-based policy experts (England, Wales, and Scotland) and (ii) representatives from multiple healthcare systems (England, France, Sweden, Canada, Poland, and Norway). Participants were encouraged to share their experiences

SUBMITTER: Farmer C 

PROVIDER: S-EPMC11570020 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature